{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:48:58Z","timestamp":1794019738794,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015739","name":"Bayer Vital GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.102996","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:39:48Z","timestamp":1782862788000},"page":"102996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lipid nanoparticles enable mRNA delivery to diverse cell types of the inner Retina"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-3514","authenticated-orcid":false,"given":"Sumit","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8513-4598","authenticated-orcid":false,"given":"Eleonora","family":"Carpentiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9676-9073","authenticated-orcid":false,"given":"Nermina","family":"Xhaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5365-6032","authenticated-orcid":false,"given":"Paula","family":"Streckenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4123-4447","authenticated-orcid":false,"given":"Vijay","family":"Renigunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-3421","authenticated-orcid":false,"given":"Moritz","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102996_bib1","first-page":"1301","article-title":"A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease","volume":"36","author":"Hinsch","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib2","article-title":"Optogenetics for visual restoration: From proof of principle to translational challenges","volume":"91","author":"Lindner","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2026.102996_bib4","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors - Implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2026.102996_bib5","first-page":"80","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib6","article-title":"Retina-directed gene therapy: Achievements and remaining challenges","volume":"271","author":"Biber","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib7","first-page":"386","article-title":"Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases","volume":"19","author":"Rouf","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2026.102996_bib8","first-page":"11","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.102996_bib9","article-title":"Targeted nonviral delivery of genome editors in vivo","volume":"121","author":"Tsuchida","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102996_bib10","article-title":"Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes","volume":"35","author":"Wang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102996_bib11","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102996_bib12","first-page":"7","article-title":"Lipid Nanoparticle-Mediated Delivery of mRNA Into the Mouse and Human Retina and Other Ocular Tissues","volume":"13","author":"Chambers","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.omtn.2026.102996_bib13","first-page":"91","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102996_bib14","first-page":"6468","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102996_bib15","first-page":"315","article-title":"Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration","volume":"307","author":"Devoldere","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102996_bib16","article-title":"Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues","volume":"121","author":"Eygeris","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102996_bib17","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102996_bib18","first-page":"1202","article-title":"Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets","volume":"161","author":"Macosko","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102996_bib19","first-page":"329","article-title":"Glial Remodeling and Neural Plasticity in Human Retinal Detachment with Proliferative Vitreoretinopathy","volume":"46","author":"Sethi","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2026.102996_bib20","first-page":"7","article-title":"Involvement of M\u00fcller glial cells in epiretinal membrane formation","volume":"247","author":"Bringmann","year":"2009","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1016\/j.omtn.2026.102996_bib21","article-title":"Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye","volume":"385","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102996_bib22","first-page":"397","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2026.102996_bib23","first-page":"1860","article-title":"Strategic lipid nanoparticle design dictates retinal delivery post inner limiting membrane disruption","volume":"16","author":"De Clerck","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omtn.2026.102996_bib24","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye - PubMed","volume":"15","author":"RC","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102996_bib25","first-page":"377","article-title":"Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration","volume":"48","author":"Pang","year":"2008","journal-title":"Vision Res."},{"key":"10.1016\/j.omtn.2026.102996_bib26","first-page":"3309","article-title":"Use of an Adult Rat Retinal Explant Model for Screening of Potential Retinal Ganglion Cell Neuroprotective Therapies","volume":"52","author":"Bull","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2026.102996_bib27","first-page":"19","article-title":"Retinal Organ Cultures as Alternative Research Models","volume":"47","author":"Schnichels","year":"2019","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.omtn.2026.102996_bib28","first-page":"7904","article-title":"In Vitro Effects of Bevacizumab Treatment on Newborn Rat Retinal Cell Proliferation, Death, and Differentiation","volume":"53","author":"Miguel","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2026.102996_bib29","first-page":"1","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102996_bib30","first-page":"699","article-title":"Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations","volume":"18","author":"Tavakoli","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2026.102996_bib31","first-page":"44","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.102996_bib32","first-page":"183","article-title":"The outer limiting membrane (OLM) revisited: clinical implications","volume":"4","author":"Omri","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.omtn.2026.102996_bib33","first-page":"471","article-title":"Muller glia and phagocytosis of cell debris in retinal tissue","volume":"231","author":"Bejarano-Escobar","year":"2017","journal-title":"J. Anat."},{"key":"10.1016\/j.omtn.2026.102996_bib34","first-page":"3680","article-title":"Muller glia phagocytose dead photoreceptor cells in a mouse model of retinal degenerative disease","volume":"33","author":"Sakami","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2026.102996_bib35","first-page":"2096","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib36","first-page":"1716","article-title":"Photodisruption of the Inner Limiting Membrane: Exploring ICG Loaded Nanoparticles as Photosensitizers","volume":"14","author":"De Clerck","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.102996_bib37","article-title":"Muller glia activation in response to inherited retinal degeneration is highly varied and disease-specific","volume":"10","author":"Hippert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102996_bib38","first-page":"e0242426","article-title":"Optimized culture of retinal ganglion cells and amacrine cells from adult mice","volume":"15","author":"Park","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102996_bib39","first-page":"3533","article-title":"Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2026.102996_bib40","first-page":"3","article-title":"Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells","volume":"40","author":"Liu","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtn.2026.102996_bib41","first-page":"800","article-title":"Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2026.102996_bib42","article-title":"RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA","volume":"3","author":"Haque","year":"2020","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib43","first-page":"530","article-title":"Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification","volume":"12","author":"Vaidyanathan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102996_bib44","article-title":"Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity","volume":"4","author":"Xiao","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2026.102996_bib45","first-page":"15","article-title":"Substantial restoration of night vision in adult mice with congenital stationary night blindness","volume":"22","author":"Varin","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102996_bib46","first-page":"129","article-title":"Ocular gene therapy for choroideremia: clinical trials and future perspectives","volume":"13","author":"Xue","year":"2018","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.omtn.2026.102996_bib47","first-page":"349","article-title":"The landscape for lipid-nanoparticle-based genomic medicines","volume":"22","author":"Verma","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102996_bib48","first-page":"484","article-title":"Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas","volume":"560","author":"Yao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102996_bib49","first-page":"103","article-title":"Stimulation of functional neuronal regeneration from M\u00fcller glia in adult mice","volume":"548","author":"Jorstad","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102996_bib50","article-title":"Nonclinical study of ixo-vec gene therapy for nAMD supports efficacy for a human dose of 6E10 vg\/eye and staggered dosing of fellow eyes","volume":"33","author":"Poulsen","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102996_bib51","article-title":"Gene therapy for glaucoma: Targeting key mechanisms","volume":"225","author":"Henderson","year":"2024","journal-title":"Vision Res."},{"key":"10.1016\/j.omtn.2026.102996_bib52","first-page":"553","article-title":"Revakinagene Taroretcel: First Approval","volume":"29","author":"Hoy","year":"2025","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib53","first-page":"22780","article-title":"Hybrid Nanoparticle-Hydrogel Systems for Drug Delivery Depots and Other Biomedical Applications","volume":"18","author":"Choi","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2026.102996_bib54","first-page":"446","article-title":"Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102996_bib55","article-title":"ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration","volume":"207","author":"Gilhooley","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2026.102996_bib56","first-page":"14","article-title":"Expression of Osteopontin in M2 and M4 Intrinsically Photosensitive Retinal Ganglion Cells in the Mouse Retina","volume":"66","author":"Kinder","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2026.102996_bib57","first-page":"676","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.102996_bib58","first-page":"374","article-title":"SNT: a unifying toolbox for quantification of neuronal anatomy","volume":"18","author":"Arshadi","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.102996_bib59","first-page":"1463","article-title":"Globally optimal stitching of tiled 3D microscopic image acquisitions","volume":"25","author":"Preibisch","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102996_bib60","first-page":"7","article-title":"TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines","volume":"19","author":"Ershov","year":"2022","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:08Z","timestamp":1788880388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001678"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102996","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles enable mRNA delivery to diverse cell types of the inner Retina","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102996"}}